TOPIC: Cardiovascular Disease TYPE: Medical Student/Resident Case Reports INTRODUCTION: Myopericarditis is inflammation of pericardium and myocardium caused by inflammatory and non-inflammatory etiologies. COVID-19 is known to cause multiple organ complications, including cardiovascular. Cases of myopericarditis have been reported, and believed to be one of the culprits of death in this disease. We present a case of myopericarditis in the setting of post-COVID-19 pneumonia CASE PRESENTATION: 56-year-old female with history of hypertension, hyperlipidemia, insulin-dependent type 2 diabetes and COVID-19 pneumonia (requiring hospitalization and nasal canula oxygenation one month prior, received 5 days of Remdesivir and 10 days of Dexamethasone);presented with four days of substernal pain, radiating to right neck and chest. On the day of admission, electrocardiogram (ECG) was sinus rhythm without ST changes and troponin was negative two times. During hospitalization, patient had episodes of fever with increased intensity of chest pain. Repeated ECG showed ST elevation in lead I, aVL, V3-V6 with ST depression in lead III;and significantly elevated troponin and pro-BNP. Echocardiogram showed mild diffuse hypokinesis with regional variations, slightly reduced left ventricular ejection fraction and normal right ventricle size and function. Patient was started on heparin drip, and underwent emergency left heart catheterization that demonstrated non-obstructive CAD. Cardiac MRI was inconclusive for late gadolinium enhancement due to respiratory motion artifact, but biventricular global hypokinesis and small pericardial effusion were evidenced. Patient persistently had high fever and elevated inflammatory markers (CRP was 406 mg/dL) despite on antibiotics, hence empiric methylprednisolone and IVIG were started. She was planned to get endomyocardial biopsy, however she improved symptomatically with concurrent decreased of inflammatory markers and troponin. Repeat echocardiogram showed normal biventricular function. Patient was discharged from the hospital after 6 days of hospitalization with cardiology and rheumatology follow up. DISCUSSION: Manifestations of myopericarditis are varied, from fatigue and shortness of breath, to severe chest pain and chest tightness. Some patients may develop right-sided heart failure, or even fulminant myocarditis with sepsis. Interestingly, manifestations may occur weeks after recovery from COVID-19. Elevations of both troponin and pro-brain natriuretic peptide (pro-BNP) are expected, but ECG may not show ST changes. Echocardiogram may show thickening of the wall, dilatation, and pericardial effusion. Gold standard for diagnosing myocarditis is endomyocardial biopsy (EMB), as recommended by AHA. However, practice is limited due to expertise requirement, risk of contagious spread, and false-negative rate. CONCLUSIONS: Differential diagnosis should always include myopericarditis in acute coronary syndrome, especially after viral infection. REFERENCE #1: Zeng J.-H., Liu Y.-X., Yuan J. First case of COVID-19 infection with fulminant myocarditis complication: case report and insights. Published online April 10. Infection. 2020. REFERENCE #2: Siripanthong B, Nazarian S, Muser D, Deo R, Santangeli P, Khanji MY, Cooper LT, Chahal AA. Recognizing COVID-19–related myocarditis: The possible pathophysiology and proposed guideline for diagnosis and management. Heart Rhythm. 2020 Sep;17(9): 1463–1471. REFERENCE #3: Inciardi R.M., Lupi L., Zaccone G., Italia L., Raffo M., Tomasoni D. Cardiac involvement in a patient with coronavirus disease 2019 (COVID-19) JAMA Cardiol. 2020;5:819–824. DISCLOSURES: No relevant relationships by Chen Chao, source=Web Response No relevant relationships by Nahla Shihab, source=Web Response No relevant relationships by Milena Vukelic, source=Web Response
Read full abstract